Sp1 and c-Myc modulate drug resistance of leukemia stem cells by regulating survivin expression through the ERK-MSK MAPK signaling pathwayYi Zhang, Yifei Wang, Hai-xuan Chen et al.|Molecular Cancer|2015Cited by 103
miR-203 inhibits proliferation and self-renewal of leukemia stem cells by targeting survivin and Bmi-1Yi Zhang, Yifei Wang, Zhe Ren et al.|Scientific Reports|2016Cited by 59
Supplementary Table 2 from Association of PD-1/PD-L1 Co-location with Immunotherapy Outcomes in Non–Small Cell Lung CancerNiki Gavrielatou, David L. Rimm, Yuting Liu et al.|Unknown|2023Cited by 0
Supplementary Figure 2 from Association of PD-1/PD-L1 Co-location with Immunotherapy Outcomes in Non–Small Cell Lung CancerNiki Gavrielatou, David L. Rimm, Yuting Liu et al.|Unknown|2023Cited by 0
Supplementary Figure 1 from Association of PD-1/PD-L1 Co-location with Immunotherapy Outcomes in Non–Small Cell Lung CancerNiki Gavrielatou, David L. Rimm, Yuting Liu et al.|Unknown|2023Cited by 0